How can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knows
Aug 2, 2024
auto_awesome
Jim Hollingshead, CEO of Insulet and former connectivity wizard at ResMed, dives into the revolutionary impact of cloud technology on diabetes care. He discusses the Omnipod 5's integration with continuous glucose monitors, paving the way for more automated diabetes management. Hollingshead also highlights the differing needs of type 1 and type 2 diabetes patients and shares exciting growth opportunities in the insulin market. His insights into navigating challenges in healthcare bring a fresh perspective to patient care improvements.
Jim Hollingshead emphasizes the transformative role of cloud technology in improving patient care through real-time data accessibility and compliance tracking.
The significant advancements represented by Insulet's OmniPod 5 platform showcase innovative insulin delivery systems connecting to glucose monitors for personalized treatment.
The upcoming DeviceTalks West event highlights the MedTech community's ongoing evolution in technology and its vital influence on patient care.
Deep dives
Connectivity's Impact in Medical Devices
The significance of connectivity in medical devices, particularly in enhancing patient care, is emphasized. Jim Hollingshead, CEO of Insulate, discusses his prior experience at ResMed, where a major shift was made by integrating cloud technology with CPAP devices to improve patient tracking and compliance. This forward-thinking approach allowed healthcare providers to access real-time data, thus streamlining operations and enhancing patient experiences. Emphasizing the need for development in connected devices, the conversation highlights how Insulate aims to replicate this success within the insulin delivery market.
The Importance of Device Talks West 2023
The Device Talks West event, scheduled for October 16th and 17th, is highlighted as a pivotal gathering for the MedTech community. The event promises keynote speakers from major companies like Baxter and Stryker, presenting a platform for networking and knowledge sharing among industry professionals. Attendees can expect discussions on emerging trends in MedTech, making it a valuable opportunity for engineers, entrepreneurs, and executives. The excitement around the event underscores the ongoing evolution of technology in healthcare and its impact on patient care.
Recent Regulatory Developments with Asensus
Asensus Surgical faces shareholder scrutiny regarding transparency in their Carl Storz merger amidst recent SEC filings. The company is under pressure to address concerns related to alleged inadequate disclosures surrounding its acquisition strategy and business operations. Asensus, known for its advancements in the surgical robotics field, remains engaged in innovations and received regulatory approval for key initiatives, including pediatric surgical applications. The ongoing developments with Asensus highlight the company's commitment to navigating challenges in a complex industry while maintaining its leading position.
Advancements in Diabetes Care with OmniPod 5
Insulate's OmniPod 5 platform represents a significant stride in diabetes management through its innovative insulin delivery system. The device connects to continuous glucose monitors like Dexcom’s G6 and the G7, providing automated insulin dosing tailored to real-time glucose levels. This approach not only enhances patient compliance but also aims to minimize the burden associated with daily diabetes management. The system's cloud connectivity allows for continued improvement and personalization of care, appealing particularly to individuals transitioning from multiple daily injections.
Future Directions for Insulate and Diabetes Technology
Insulate's trajectory points toward a future where diabetes management is further augmented by enhanced technology integration and data analytics. With ongoing studies aimed at gaining FDA approval for type 2 diabetes indications, the company's focus is on broadening its reach to a larger patient population. There is an optimism surrounding the use of machine learning and AI for personalized patient care, which promises to simplify diabetes management routines. By identifying patterns through patient data, Insulate envisions a healthcare landscape where technology alleviates the challenges of living with diabetes.
In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets
MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor.
This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode